The Src kinase p56(lck) up-regulates VLA-4 integrin affinity. Implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin

J Biol Chem. 2001 Apr 27;276(17):13891-901. doi: 10.1074/jbc.M004939200. Epub 2000 Dec 1.

Abstract

In circulating lymphocytes, the VLA-4 integrin preexists in multiple affinity states that mediate spontaneous tethering, rolling, and arrest on its endothelial ligand, vascular cell adhesion molecule-1 (VCAM-1). The regulation and function of VLA-4 affinity in lymphocytes has never been elucidated. We show here that p56(lck), the major Src kinase in T cells, is a key regulator of high affinity VLA-4. This high affinity is essential for the rapid development of firm adhesion of resting T cells to VCAM-1 and to their extracellular matrix ligand, fibronectin. Lck-regulated VLA-4 function does not require intact TCR nor several key components of the TCR signaling pathway, including ZAP-70 and SLP-76. Furthermore, stimulation of p56(lck) by the phosphatase inhibitor, pervanadate, triggers firm VLA-4-dependent adhesion to VCAM-1. Although Lck is not required for chemokine receptor signaling to mitogen-activated protein kinase, the presence of Lck-regulated high affinity VLA-4 also facilitates firm adhesion triggered by the chemokine, SDF-1, at short-lived contacts. Surprisingly, bond formation rates, ability to tether cells to VLA-4 ligand, and VLA-4 tether bond stability under shear flow are not affected by VLA-4 affinity or Lck activity. Thus, the ability of high affinity VLA-4 to arrest cells on VCAM-1 under flow arises from instantaneous post-ligand strengthening rather than from increased kinetic stability of individual VLA-4 bonds. These results suggest that p56(lck) maintains high affinity VLA-4 on circulating lymphocytes, which determines their ability to strengthen VLA-4 adhesion and rapidly respond to proadhesive chemokine signals at endothelial sites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cell Adhesion / drug effects
  • Dose-Response Relationship, Drug
  • Endothelium / metabolism
  • Enzyme Inhibitors / pharmacology
  • Fibronectins / metabolism
  • Flow Cytometry
  • Humans
  • Integrin alpha4beta1
  • Integrins / metabolism*
  • Interleukin-2 / metabolism
  • Jurkat Cells
  • Kinetics
  • Ligands
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / metabolism*
  • Lymphocytes / metabolism
  • Phosphotyrosine / metabolism
  • Protein Binding
  • Receptors, Lymphocyte Homing / metabolism*
  • Signal Transduction
  • T-Lymphocytes / metabolism
  • Up-Regulation*
  • Vanadates / pharmacology
  • Vascular Cell Adhesion Molecule-1 / metabolism

Substances

  • Enzyme Inhibitors
  • Fibronectins
  • Integrin alpha4beta1
  • Integrins
  • Interleukin-2
  • Ligands
  • Receptors, Lymphocyte Homing
  • Vascular Cell Adhesion Molecule-1
  • pervanadate
  • Phosphotyrosine
  • Vanadates
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)